Zelapar selegine oral dissolving tablet regulatory update

AMRN said it received an approvable letter from the FDA for an NDA filed by ELN for Zelapar as an adjunct treatment to levodopa to treat Parkinson's disease. ELN has U.S. marketing and distribution ri...